20.55
price up icon7.82%   1.49
after-market アフターアワーズ: 20.55
loading
前日終値:
$19.06
開ける:
$18.91
24時間の取引高:
599.64K
Relative Volume:
0.59
時価総額:
$547.71M
収益:
$17.16M
当期純損益:
$-163.62M
株価収益率:
-3.3799
EPS:
-6.08
ネットキャッシュフロー:
$-121.61M
1週間 パフォーマンス:
+26.54%
1か月 パフォーマンス:
+24.47%
6か月 パフォーマンス:
-41.59%
1年 パフォーマンス:
-4.29%
1日の値動き範囲:
Value
$18.91
$20.75
1週間の範囲:
Value
$16.03
$20.75
52週間の値動き範囲:
Value
$12.21
$41.31

Anaptysbio Inc Stock (ANAB) Company Profile

Name
名前
Anaptysbio Inc
Name
セクター
Healthcare (1151)
Name
電話
858-362-6295
Name
住所
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Name
職員
136
Name
Twitter
@anaptysbio
Name
次回の収益日
2024-11-08
Name
最新のSEC提出書
Name
ANAB's Discussions on Twitter

ANAB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ANAB
Anaptysbio Inc
20.55 547.71M 17.16M -163.62M -121.61M -6.08
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
489.10 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.16 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
596.20 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
234.56 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
230.98 26.16B 3.81B -644.79M -669.77M -6.24

Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-04 開始されました Wolfe Research Outperform
2024-12-11 ダウングレード H.C. Wainwright Buy → Neutral
2024-12-02 ダウングレード BTIG Research Buy → Neutral
2024-07-22 開始されました H.C. Wainwright Buy
2024-07-19 アップグレード JP Morgan Neutral → Overweight
2024-04-16 開始されました Leerink Partners Outperform
2024-04-11 開始されました Wells Fargo Overweight
2024-03-12 アップグレード Wedbush Neutral → Outperform
2024-02-26 開始されました BTIG Research Buy
2024-02-21 開始されました Stifel Buy
2024-02-16 開始されました Piper Sandler Overweight
2023-05-22 アップグレード JP Morgan Underweight → Neutral
2023-05-18 開始されました TD Cowen Outperform
2023-01-06 ダウングレード Raymond James Outperform → Mkt Perform
2022-11-01 アップグレード Guggenheim Neutral → Buy
2022-09-19 再開されました H.C. Wainwright Buy
2022-09-13 ダウングレード Truist Buy → Hold
2022-09-01 開始されました Raymond James Outperform
2022-03-22 ダウングレード Guggenheim Buy → Neutral
2021-06-22 開始されました H.C. Wainwright Buy
2021-05-21 開始されました UBS Neutral
2021-03-16 アップグレード Truist Hold → Buy
2021-03-09 ダウングレード Wedbush Outperform → Neutral
2021-03-08 ダウングレード JP Morgan Overweight → Underweight
2021-02-11 アップグレード JP Morgan Underweight → Overweight
2020-10-27 アップグレード Wedbush Neutral → Outperform
2020-10-14 アップグレード Guggenheim Neutral → Buy
2019-11-08 ダウングレード JP Morgan Overweight → Underweight
2019-11-08 ダウングレード Jefferies Buy → Hold
2019-11-08 ダウングレード SunTrust Buy → Hold
2019-11-08 ダウングレード Wedbush Outperform → Neutral
2019-06-21 ダウングレード Credit Suisse Outperform → Neutral
2019-06-21 ダウングレード Stifel Buy → Hold
2018-12-20 開始されました H.C. Wainwright Buy
2018-11-21 開始されました JP Morgan Overweight
2018-07-19 開始されました Credit Suisse Outperform
2018-04-04 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2018-03-27 繰り返されました Stifel Buy
2018-03-06 繰り返されました Stifel Buy
2018-02-15 繰り返されました SunTrust Buy
2018-01-23 繰り返されました Credit Suisse Outperform
2017-11-15 開始されました SunTrust Buy
2017-11-09 開始されました Jefferies Buy
2017-10-11 繰り返されました RBC Capital Mkts Outperform
2017-09-15 開始されました RBC Capital Mkts Outperform
すべてを表示

Anaptysbio Inc (ANAB) 最新ニュース

pulisher
Apr 18, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by Trexquant Investment LP - MarketBeat

Apr 18, 2025
pulisher
Apr 17, 2025

Vanguard Group Inc. Has $24.41 Million Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

Apr 17, 2025
pulisher
Apr 17, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Apr 17, 2025
pulisher
Apr 16, 2025

Vanguard Group Inc. Increases Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Apr 16, 2025
pulisher
Apr 16, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Apr 16, 2025
pulisher
Apr 14, 2025

How To Trade (ANAB) - news.stocktradersdaily.com

Apr 14, 2025
pulisher
Apr 14, 2025

Psoriasis Market Outlook in the 7MM Through 2034: In-Depth Analysis by Psoriasis Type | DelveInsight - GlobeNewswire Inc.

Apr 14, 2025
pulisher
Apr 13, 2025

KLP Kapitalforvaltning AS Purchases New Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

ADAR1 Capital Management LLC Sells 165,419 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

Apr 12, 2025
pulisher
Apr 03, 2025

AnaptysBio, Inc.'s (NASDAQ:ANAB) Price Is Right But Growth Is Lacking After Shares Rocket 30% - simplywall.st

Apr 03, 2025
pulisher
Apr 01, 2025

AnaptysBio (NASDAQ:ANAB) Trading 2.5% HigherTime to Buy? - MarketBeat

Apr 01, 2025
pulisher
Mar 31, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Stock Holdings Increased by Swiss National Bank - Defense World

Mar 31, 2025
pulisher
Mar 29, 2025

How to Take Advantage of moves in (ANAB) - news.stocktradersdaily.com

Mar 29, 2025
pulisher
Mar 29, 2025

AnaptysBio (NASDAQ:ANAB) Shares Gap UpShould You Buy? - MarketBeat

Mar 29, 2025
pulisher
Mar 29, 2025

Charles Schwab Investment Management Inc. Acquires 5,733 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

AnaptysBio (NASDAQ:ANAB) Shares Down 4.1%Here's What Happened - MarketBeat

Mar 28, 2025
pulisher
Mar 28, 2025

AnaptysBio (NASDAQ:ANAB) to Repurchase $75.00 million in Stock - MarketBeat

Mar 28, 2025
pulisher
Mar 27, 2025

Bank of New York Mellon Corp Sells 1,972 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

Leerink Partners Sticks to Their Buy Rating for AnaptysBio (ANAB) - The Globe and Mail

Mar 27, 2025
pulisher
Mar 26, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Mar 26, 2025
pulisher
Mar 25, 2025

AnaptysBio (ANAB) Moves 9.5% Higher: Will This Strength Last? - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

AnaptysBio (NASDAQ:ANAB) to Repurchase $75.00 million in Shares - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

AnaptysBio Shares Jump on Buyback Program Authorization - MarketWatch

Mar 24, 2025
pulisher
Mar 24, 2025

Crude Oil Gains 1%; US Composite PMI Surges In March - Benzinga

Mar 24, 2025
pulisher
Mar 24, 2025

Anaptys Announces Stock Repurchase Plan - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

AnaptysBio authorizes $75 million stock buyback plan By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Anaptys announces $75 million stock repurchase plan - MSN

Mar 24, 2025
pulisher
Mar 24, 2025

AnaptysBio Announces $75 Mln Stock Repurchase Plan - Nasdaq

Mar 24, 2025
pulisher
Mar 24, 2025

AnaptysBio stock rises following stock repurchase plan By Investing.com - Investing.com Canada

Mar 24, 2025
pulisher
Mar 24, 2025

Intuitive Machines Posts Q4 Results, Joins Tesla, AnaptysBio, Coherent And Other Big Stocks Moving Higher On Monday - Benzinga

Mar 24, 2025
pulisher
Mar 24, 2025

AnaptysBio Approves $75 Million Buyback Plan; Shares Rise -March 24, 2025 at 09:50 am EDT - Marketscreener.com

Mar 24, 2025
pulisher
Mar 24, 2025

AnaptysBio authorizes $75 million stock buyback plan - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

AnaptysBio, Inc. Authorizes $75 Million Stock Repurchase Plan - Nasdaq

Mar 24, 2025
pulisher
Mar 23, 2025

AnaptysBio (NASDAQ:ANAB) Trading Up 4.4%Still a Buy? - MarketBeat

Mar 23, 2025
pulisher
Mar 22, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

AlphaQuest LLC Purchases 4,237 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Position Raised by Victory Capital Management Inc. - MarketBeat

Mar 19, 2025
pulisher
Mar 16, 2025

Victory Capital Management Inc. Purchases 97,200 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Mar 16, 2025
pulisher
Mar 15, 2025

Wells Fargo Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks - markets.businessinsider.com

Mar 15, 2025
pulisher
Mar 10, 2025

AnaptysBio (NASDAQ:ANAB) Price Target Raised to $42.00 - MarketBeat

Mar 10, 2025
pulisher
Mar 09, 2025

Rhumbline Advisers Grows Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Mar 09, 2025

Anaptysbio Inc (ANAB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.04
price up icon 2.51%
$72.65
price up icon 3.49%
$32.60
price up icon 1.27%
$24.61
price up icon 6.77%
$98.76
price up icon 0.52%
biotechnology ONC
$230.98
price up icon 1.24%
大文字化:     |  ボリューム (24 時間):